[Asia Economy Reporter Minwoo Lee] Enbionia announced on the 9th that it has decided to acquire 200,000 shares of Cefratech worth 1 billion KRW by participating in a third-party allotment paid-in capital increase. Enbionia stated, "The goal is to enter the membrane market by securing membrane technology and to create synergy with existing businesses."



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing